Old Web
English
Sign In
Acemap
>
authorDetail
>
Axel Maier
Axel Maier
Hoffmann-La Roche
Chemistry
Chemical synthesis
NOP
Biological activity
Stereochemistry
4
Papers
42
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Design and synthesis of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of GlyT1 inhibitors : Achieving selectivity against the μ opioid and nociceptin/orphanin FQ peptide (NOP) receptors
2006
Bioorganic & Medicinal Chemistry Letters
Daniela Alberati
Simona M. Ceccarelli
Synese Jolidon
Eva A. Krafft
Anke Kurt
Axel Maier
Emmanuel Pinard
Henri Stalder
Deborah Studer
Andrew William Thomas
Daniel Zimmerli
Show All
Source
Cite
Save
Citations (11)
Discovery of 4-substituted-8-(2-hydroxy-2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with improved metabolic stability
2006
Bioorganic & Medicinal Chemistry Letters
Daniela Alberati
Dominik Hainzl
Synese Jolidon
Eva A. Krafft
Anke Kurt
Axel Maier
Emmanuel Pinard
Andrew William Thomas
Daniel Zimmerli
Show All
Source
Cite
Save
Citations (14)
Discovery of 4-substituted-8-(2-hydroxy-2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with improved metabolic stability
2006
Bioorganic & Medicinal Chemistry Letters
Daniela Alberati
Dominik Hainzl
Synese Jolidon
Eva A. Krafft
Anke Kurt
Axel Maier
Emmanuel Pinard
Andrew Thomas
Daniel Zimmerli
Show All
Source
Cite
Save
Citations (17)
A Straightforward and Efficiently Scaleable Synthesis of Novel Racemic 4-Substituted-2,8-diazaspiro[4.5]decan-1-one Derivatives
2005
Synthesis
Eva A. Krafft
Anke Kurt
Axel Maier
Andrew William Thomas
Daniel Zimmerli
Show All
Source
Cite
Save
Citations (0)
1